Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer - Ultra-HART
Condition: Prostate Cancer, Adaptive Radiotherapy, Quality of Life
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT06355050
Sponsor: Jena University Hospital
Phase:
Eligibility:
- Age: minimum 18 Years maximum 120 Years
- Gender: Male
Inclusion Criteria:
- no androgen deprivation therapy within the last 2 months prior to RT
- good performance status (Eastern Cooperative Oncology Group, ECOG, 0/1)
- no secondary malignancy
View trial on ClinicalTrials.gov